Die klinischen Studien sind in der Entwicklung von Arzneimitteln der zentrale Schritt. Hier finden Sie eine Darstellung aller laufenden klinischen Studien von Biotest.
Immunologie
Titel |
Indikation |
Status |
|---|---|---|
|
|
||
| Cytotect (Studie 963) | CMV Prophylaxe in der Schwangerschaft | Studie beendet |
|
Prävention der Übertragung von humanem Cytomegalievirus (HCMV) von der Mutter auf den Fetus durch die Gabe von Virus spezifischem Hyperimmunglobulin bei schwangeren Frauen mit primärer HCMV Infektion Link clinicaltrialsregister.eu |
||
| BT-063 (Studie 977) | Systemischer Lupus Erythematodes | Studie beendet |
|
A prospective, open-label, mono-centre study to investigate safety, tolerability, pharmacokinetic and immunological properties of single IV doses of the humanised anti-IL-10 monoclonal antibody BT063 |
||
| BT-063 (Studie 990) | Systemischer Lupus Erythematodes | Studie beendet |
Hämatologie
Titel |
Indikation |
Status |
|---|---|---|
|
|
||
| Indatuximab Ravtansine* (Studie 989) | Solide Tumore | Studie läuft |
|
An open-label, twostage Phase I/IIa dose escalation study of BT062 in metastatic triple receptor-negative breast cancer and in metastatic transitional cell carcinoma of the urinary bladder Link clinicaltrialsregister.eu |
||
| Indatuximab Ravtansine (Studie 969) | Multiples Myelom | Studie beendet |
|
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma |
||
| Indatuximab Ravtansine (Studie 975) | Multiples Myelom | Studie beendet |
|
Safety and Dose Determining Multi-dose Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma |
||
| Indatuximab Ravtansine (Studie 983) | Multiples Myelom | Studie läuft |
|
BT062 in Combination With Lenalidomide/Dexamethasone in Patients With Multiple Myeloma Link clinicaltrials.gov |
||
* Weitere Informationen finden Sie unter Neuigkeiten aus der Forschung.
Intensivmedizin
Titel |
Indikation |
Status |
|---|---|---|
|
|
||
| Fibrinogen (Studie 995) | Erworbener Fibrinogenmangel | Studie läuft |
|
A randomized, active-controlled, multicenter, phase III study investigating efficacy and safety of intra-operative use of BT524 (human fibrinogen concentrate) in subjects undergoing major spine surgery (AdFIrst). Link clinicaltrials.gov |
||
| Fibrinogen (Studie 984) | Angeborener Fibrinogenmangel | Studie läuft |
|
A prospective, open-label, phase I/III study investigating pharmacokinetic properties of BT524 and efficacy and safety of BT524 in the treatment and prophylaxis of bleeding in patients with congenital fibrinogen deficiency. Link clinicaltrials.gov |
||
| IgM Concentrate (Studie 970) | Schwere ambulant erworbene Lungenentzündung | Studie beendet |
|
A prospective, randomised, placebo-controlled, and single-blind phase I study investigating safety, tolerability, and pharmacokinetic properties of IgM Concentrate BT086 in healthy subjects |
||
| Trimodulin (Studie 982) | Schwere ambulant erworbene Lungenentzündung | Studie beendet |
|
A Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group, Adaptive Group-sequential Phase II Study, to Determine the Efficacy and Safety of BT086 as an Adjunctive Treatment i Severe Community Acquired Pneumonia (sCAP) Link clinicaltrials.gov |
||